Hepatitis C treatment and long-term outcome of patients with hepatocellular carcinoma after resection.
Hou-Ying ChengRey-Heng HuChih-Yang HsiaoMing-Chih HoYao-Ming WuPo-Huang LeeCheng-Maw HoPublished in: Journal of gastroenterology and hepatology (2023)
In patients with hepatitis C virus, antiviral treatment suggested OS benefit for primary hepatocellular carcinoma after resection, and DAAs might be protective against hepatic decompensation. Following adjustment for oncological factors, IFN and DAA treatment was not significantly advantageous relative to the other.